Background. Oesophageal surgery causes morbidity and mortality from respiratory complications. We tested the possibility that prostaglandin E 1 (PGE 1 ) could reduce inflammatory cytokine responses and improve gas exchange after oesophagectomy.
Morbidity after oesophagectomy has decreased over the last few decades owing to technical modifications and improvements in perioperative care. [1] [2] [3] However, the mortality of the transthoracic approach remains at 5-12%. [4] [5] [6] Postoperative pulmonary complications such as pneumonia, acute lung injury and acute respiratory distress syndrome prolong the duration of mechanical ventilation and are strongly associated with morbidity and mortality. 6 7 Generally, proinflammatory cytokines are important in the progression of lung injury. Increased serum IL-6 and IL-8 concentrations are found after oesophageal surgery, [8] [9] [10] [11] and these increases could lead to acute lung injury. [12] [13] [14] Prostaglandin E 1 (PGE 1 ) is a pulmonary and systemic vasodilator with anti-inflammatory properties. 15 A low dose of PGE 1 (20 ng kg À1 min À1 ) reduced the increases of IL-6 and IL-8 caused by reperfusion injury in cardiopulmonary bypass without reducing blood pressure. 16 Therefore, PGE 1 might have beneficial effects on inflammatory responses in oesophageal surgery. We studied the effects of PGE 1 on proinflammatory cytokine responses and gas exchange in patients undergoing oesophagectomy for oesophageal cancer. We studied patients having right-sided transthoracic oesophagectomy with cervical oesophagogastrostomy and three-field lymph node dissection, which is probably the most invasive procedure in oesophageal surgery. performed between March 2001 and July 2002. Written informed consent was obtained from patients about to have right-sided transthoracic oesophagectomy with threefield lymph node dissection for thoracic oesophageal cancer. Reconstruction using stomach and cervical oesophagogastrostomy was performed. Exclusion criteria were: trans-hiatal oesophagectomy, minimal invasive techniques using thoracoscopy or laparoscopy, reconstruction using a segment of colon or jejunum, preoperative steroid administration, and age greater than 75 yr.
The same experienced surgical team (25 or more transthoracic oesophagectomies performed every year) conducted each operation. Patients were allocated to one of two groups using closed envelopes: the PGE 1 group and the control group. Patients in the PGE 1 group received PGE 1 20 ng kg À1 min
À1
(Prostandin; Ono Pharmaceutical, Osaka, Japan) from induction of anaesthesia until the end of surgery. We did not give a placebo to the control group as it was very difficult to obtain patients' consent if the anaesthetists were not aware of the agents they were using during anaesthesia. However the anaesthetists and intensive care physicians who participated in anaesthetic management or postoperative cardiorespiratory care did not know the study objectives. All patients received dopamine 2-8 mg kg À1 min À1 during anaesthesia. If the mean blood pressure were to decrease to less than 80% of the preoperative value in spite of fluid administration and increasing dopamine to a dose of 10 mg kg À1 min À1 , administration of PGE 1 would be stopped. Anaesthesia was induced with propofol 2-2.5 mg kg À1 and a double-lumen bronchial tube was placed after giving vecuronium 10 mg i.v. Initial ventilation settings were a tidal volume of 10 ml kg À1 based on ideal body weight, a respiratory rate of 10 =min, an inspiratory=expiratory ratio of 1:2 and an FI O 2 of 0.5. General anaesthesia was maintained with sevoflurane in combination with epidural anaesthesia using 0.25% bupivacaine. During oesophagectomy with right-sided thoracotomy in a left lateral decubitus position, one-lung ventilation was performed. The dependent lung was ventilated with FI O 2 between 0.5-1.0, using oxygen and air mixture to keep Sp O 2 >90. Tidal volume was maintained at 10 ml kg À1 . If the peak inspiratory pressure exceeded 30 cm H 2 O, the position of the double lumen tube was confirmed with a fibre-optic bronchoscope and bronchial suction was also carried out. Tidal volume was also reduced to 8 ml kg À1 if necessary. After removal of the thoracic oesophagus and dissection of the posterior mediastinal lymph nodes (around the recurrent nerve and oesophagus), the right lung was reinflated manually until collapse could not be seen and two-lung ventilation was resumed. FI O 2 was decreased to <0.5 and 5 cm H 2 O PEEP was added, and other ventilation settings were left unchanged. After the thoracic procedures, the patients were placed supine and the bronchial tube was changed for a single-lumen orotracheal tube. At laparotomy, a gastric tube was constructed and cervical oesophagogastrostomy was done. After surgery, the patients were transferred to the intensive care unit, sedated with midazolam and buprenorphine i.v., and ventilated mechanically. Postoperative analgesia was provided with continuous epidural infusion of bupivacaine 0.25% in combination with buprenorphine 0.2-0.3 mg day À1 . The patients were weaned from mechanical ventilation and extubated on or after the first day after surgery if the FI O 2 was <0.4, Pa O 2 =FI O 2 was >33.3 kPa, the forced vital capacity was >15 ml kg À1 , and the circulation was stable. If the cough reflex was not present, percutaneous cricothyrotomy with a Minitrach II Ò (Sims Portex, Hythe, UK) was used for suctioning of tracheal sputum.
We took blood samples for blood gas analysis and interleukin (IL)-6 and IL-8 measurements at induction of anaesthesia, at the end of thoracotomy, at the end of the operation, 2 h after surgery, 12 h after the operation and before extubation. The ventilation settings were kept constant for at least 10 min before blood sampling, and blood pressure was recorded simultaneously with blood sampling. Arterial blood samples were collected into sterile 10 ml syringes and centrifuged at 1200 g for 10 min at 4 C. The serum was stored at -80 C until analysis. IL-6 and IL-8 were measured by enzyme-linked immunosorbent assay (Fujirebio, Tokyo, Japan) according to the instructions of the manufacturer.
The data are expressed as median (interquartile range 
Results
Fourteen patients were studied. The patients' characteristics are shown in Table 1 . The operative time, duration of anaesthesia, duration of thoracotomy and the volumes of intraoperative fluid administration and blood loss were similar between the two groups. One patient in each group developed pneumonia. In one patient in the control group, extubation was delayed for 9 days because of pneumonia and acute respiratory distress syndrome, and in the PGE 1 group one patient developed pneumonia after discharge from the intensive care unit. No patients died after surgery. Time to extubation and discharge from the intensive care unit were very similar in the two groups.
There were no differences in systolic blood pressure, arterial blood pH and Pa CO 2 during and after surgery between the two groups ( Table 2 ). In no case did PGE 1 infusion have to be stopped because of hypotension. The Pa O 2 =FI O 2 ratio during surgery was similar for the two groups (Table 2 ), but the Pa O 2 =FI O 2 values were greater in the PGE 1 group 2 h after surgery and significantly greater on the first day after surgery. Serum IL-6 increased after surgery in both groups, but the increase was less after PGE 1 administration (Table 3) . The IL-6 values in the PGE 1 group were significantly less at the end of the operation and 2 h after surgery in comparison with the control group. IL-8 values did not differ between the control group and the PGE 1 group. There was a significant correlation between IL-6 and the Pa O 2 =FI O 2 ratio on the first day after surgery (r=À0.724, P<0.01) (Fig. 1) .
Discussion
We found that serum IL-6 increased after oesophagectomy and that PGE 1 attenuated this increase and oxygenation was better in the early postoperative period.
The effect of PGE 1 on proinflammatory cytokines seems to differ depending on the surgical site. Sugawara et al. 17 reported that PGE 1 given at 20 ng kg À1 min À1 increased plasma IL-6 concentrations after a Pringle manoeuvre in cirrhotic patients undergoing subsegmental hepatectomy. They concluded that PGE 1 had cytoprotective effects, as IL-6 is a potent stimulator of acute-phase protein production by the liver and promotes repair and regeneration of liver tissues. On the other hand, Kawamura et al. 16 gave PGE 1 at 20-50 ng kg À1 min À1 during cardiac surgery with cardiopulmonary bypass and reduced the increases of IL-6 and IL-8 after declamping the aorta. PGE 1 also reduced the increases in serum troponin-T and an isozyme of creatine kinase with muscle and brain subunits. 16 It was proposed that IL-6 and IL-8 production was involved in myocardial ischaemiareperfusion injury, and that PGE 1 protected against myocardial injury by inhibiting proinflammatory cytokines.
In assessing the present study, the effects of conditions before and during surgery on postoperative pulmonary complications must be considered. Age, body mass index, vital capacity and smoking influence postoperative pulmonary function, 3 5 18 but these did not differ between the groups. Surgical factors, such as approach, choice of conduit 19 and skill of the operator, 20 could also affect patient morbidity, but the surgical procedure in this study was uniform and done by the same surgical team. Intraoperative conditions such as operation time, thoracotomy time, blood loss and volume of fluid administration 7 were also similar for the two groups. We found that PGE 1 did not cause systemic hypotension or impairment of gas exchange during surgery. Improvement of oxygenation, with a reduced increase of IL-6 in the PGE 1 group, suggested that inflammatory responses in the lung might be reduced by PGE 1 , and impaired oxygenation was thus prevented. Reid et al. 21 measured lung protein accumulation of radiolabelled transferrin using a double-isotope system in patients undergoing oesophagogastrectomy. Increased pulmonary endothelial permeability occurred after oesophagectomy, shown by increased protein accumulation. Intraoperative prostaglandin E 1 in oesophagectomy Gee et al. 22 reported that PGE 1 reduced the increase in lung vascular permeability in a model of lung vascular injury induced by complement in anaesthetized sheep. It is possible that the increase in extravascular lung water during surgery was reduced by PGE 1 , so that oxygenation was better after surgery.
We could not measure inflammatory cytokines in the bronchoalveolar lavage fluid, but Abe and colleagues 8 found that increased concentrations of IL-6 come from alveolar and bronchial cells, not from alveolar macrophages. They showed that plasma concentrations of IL-6 reached a peak 12 h after transthoracic oesophagectomy, and this correlated with IL-6 production by cultivated lung tissue. A more recent study showed that alveolar macrophages also expressed IL-6 or IL-8 in oesophageal surgery 9 and that expression was closely related to postoperative respiratory failure.
While reducing increases in serum IL-6, PGE 1 did not affect IL-8 in the present study. Postoperative IL-8 did not increase in some cases and the increase in serum IL-8 was not so evident as that of IL-6. This might be related to the relatively low incidence of pulmonary complications in our patients. Tsukada et al. 23 showed that the IL-8 concentration in bronchoalveolar lavage fluid did not change after oesophagectomy in patients without postoperative pneumonia, while it significantly increased after surgery in patients with postoperative pneumonia.
There are several limitations of the present study. First, although randomized, it was not masked or placebocontrolled. However, all of the patients in the present study were anaesthetized by one of several residents according to the protocol used during our routine practice for thoracic anaesthesia, and postoperative respiratory care and blood sampling and measurements were performed by personnel who were blinded to the treatment protocol. Secondly, although we found that the study demonstrated that intraoperative PGE 1 maintained oxygenation postoperatively, the effect of PGE 1 on morbidity and mortality remains to be tested because of the relatively small patient population in the study. Although further randomized trials of adequate sample size are anticipated, surgical approaches to oesophageal cancer have become diverse, depending on the patient's physical status and tumor stage. Less invasive procedures, such as thoracoscopic 24 and hand-assisted thoracoscopic 25 oesophagectomy, have now become popular. These approaches could reduce inflammatory responses and postoperative pulmonary complications, and this is worth investigating. Thirdly, PGE 1 treatment has a theoretical risk of impaired tumour surveillance, especially during cancer surgery. PGE 1 suppressed natural killer cell activity in in vitro 26 and in vivo 27 animal studies. Suppression of natural killer cells can increase susceptibility to tumour recurrence or metastasis. 
